Additionally, we constructed a prognostic model relevant to ovarian cancer, emphasizing the potential significance of the high-risk gene RPL23 and the Oxidative Phosphorylation pathway as crucial targets for ovarian cancer treatment and drug resistance. Here, RPL23 is linked to ovarian carcinoma.